47 related articles for article (PubMed ID: 7753546)
1. Cell type-specific trans-activation by the B-myb gene product: requirement of the putative cofactor binding to the C-terminal conserved domain.
Tashiro S; Takemoto Y; Handa H; Ishii S
Oncogene; 1995 May; 10(9):1699-707. PubMed ID: 7753546
[TBL] [Abstract][Full Text] [Related]
2. The human A-myb protein is a strong activator of transcription.
Golay J; Loffarelli L; Luppi M; Castellano M; Introna M
Oncogene; 1994 Sep; 9(9):2469-79. PubMed ID: 8058310
[TBL] [Abstract][Full Text] [Related]
3. Characterization and cell cycle-regulated expression of mouse B-myb.
Lam EW; Robinson C; Watson RJ
Oncogene; 1992 Sep; 7(9):1885-90. PubMed ID: 1501895
[TBL] [Abstract][Full Text] [Related]
4. B-Myb function can be markedly enhanced by cyclin A-dependent kinase and protein truncation.
Lane S; Farlie P; Watson R
Oncogene; 1997 May; 14(20):2445-53. PubMed ID: 9188859
[TBL] [Abstract][Full Text] [Related]
5. An alternatively spliced isoform of B-Myb is a transcriptional inhibitor.
Horstmann S; Ferrari S; Klempnauer KH
Oncogene; 2000 Nov; 19(48):5428-34. PubMed ID: 11114719
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional regulation by the carboxyl terminus of c-Myb depends upon both the Myb DNA-binding domain and the DNA recognition site.
Dubendorff JW; Lipsick JS
Oncogene; 1999 Jun; 18(23):3452-60. PubMed ID: 10376523
[TBL] [Abstract][Full Text] [Related]
7. B-Myb overcomes a p107-mediated cell proliferation block by interacting with an N-terminal domain of p107.
Joaquin M; Bessa M; Saville MK; Watson RJ
Oncogene; 2002 Nov; 21(52):7923-32. PubMed ID: 12439743
[TBL] [Abstract][Full Text] [Related]
8. B-Myb repressor function is regulated by cyclin A phosphorylation and sequences within the C-terminal domain.
Petrovas C; Jeay S; Lewis RE; Sonenshein GE
Oncogene; 2003 Apr; 22(13):2011-20. PubMed ID: 12673206
[TBL] [Abstract][Full Text] [Related]
9. The chicken A-myb protein is a transcriptional activator.
Foos G; Grimm S; Klempnauer KH
Oncogene; 1994 Sep; 9(9):2481-8. PubMed ID: 8058311
[TBL] [Abstract][Full Text] [Related]
10. DNA binding and transactivation activity of A-myb, a c-myb-related gene.
Ma XP; Calabretta B
Cancer Res; 1994 Dec; 54(24):6512-6. PubMed ID: 7987850
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of cyclin A/Cdk2 phosphorylation impairs B-Myb transactivation function without affecting interactions with DNA or the CBP coactivator.
Bessa M; Saville MK; Watson RJ
Oncogene; 2001 Jun; 20(26):3376-86. PubMed ID: 11423988
[TBL] [Abstract][Full Text] [Related]
12. TATA-box dependent trans-activation of the human HSP70 promoter by Myb proteins.
Foos G; Natour S; Klempnauer KH
Oncogene; 1993 Jul; 8(7):1775-82. PubMed ID: 8510924
[TBL] [Abstract][Full Text] [Related]
13. Solution structure of the B-Myb DNA-binding domain: a possible role for conformational instability of the protein in DNA binding and control of gene expression.
McIntosh PB; Frenkiel TA; Wollborn U; McCormick JE; Klempnauer KH; Feeney J; Carr MD
Biochemistry; 1998 Jul; 37(27):9619-29. PubMed ID: 9657674
[TBL] [Abstract][Full Text] [Related]
14. Murine A-myb: evidence for differential splicing and tissue-specific expression.
Mettus RV; Litvin J; Wali A; Toscani A; Latham K; Hatton K; Reddy EP
Oncogene; 1994 Oct; 9(10):3077-86. PubMed ID: 8084617
[TBL] [Abstract][Full Text] [Related]
15. The myb gene family in cell growth, differentiation and apoptosis.
Oh IH; Reddy EP
Oncogene; 1999 May; 18(19):3017-33. PubMed ID: 10378697
[TBL] [Abstract][Full Text] [Related]
16. c-Myb acetylation at the carboxyl-terminal conserved domain by transcriptional co-activator p300.
Tomita A; Towatari M; Tsuzuki S; Hayakawa F; Kosugi H; Tamai K; Miyazaki T; Kinoshita T; Saito H
Oncogene; 2000 Jan; 19(3):444-51. PubMed ID: 10656693
[TBL] [Abstract][Full Text] [Related]
17. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
18. The A-myb gene is preferentially expressed in tonsillar CD38+, CD39-, and sIgM- B lymphocytes and in Burkitt's lymphoma cell lines.
Golay J; Erba E; Bernasconi S; Peri G; Introna M
J Immunol; 1994 Jul; 153(2):543-53. PubMed ID: 8021494
[TBL] [Abstract][Full Text] [Related]
19. E2F binding is required but not sufficient for repression of B-myb transcription in quiescent fibroblasts.
Bennett JD; Farlie PG; Watson RJ
Oncogene; 1996 Sep; 13(5):1073-82. PubMed ID: 8806697
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the cyclin D1 and cyclin A1 promoters by B-Myb is mediated by Sp1 binding sites.
Bartusel T; Schubert S; Klempnauer KH
Gene; 2005 May; 351():171-80. PubMed ID: 15922873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]